Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    Add magnesium to treatment of AF with rapid ventricular response

    May 16, 2019

    Is magnesium a useful addition to atrioventricular (AV) nodal blockers in achieving faster rate control for atrial fibrillation (AF) with rapid ventricular response in emergency department patients?

  • 1
    News

    Aspirin shows little benefit for primary prevention of vascular disease in diabetes

    May 15, 2019

    Is aspirin for primary prevention of cardiovascular events in patients with diabetes worth the risk of adverse bleeding events?

  • News

    Severe OSA increases cardiovascular risk after surgery

    May 14, 2019

    General anesthetics, sedatives, and postoperative analgesics are potent respiratory depressants that relax the upper airway dilator muscles and impair ventilatory response to hypoxemia and hypercapnia.

  • 1
    News

    AFib screening cuts hospitalizations and ED visits

    May 11, 2019

    NEW ORLEANS – People diagnosed with atrial fibrillation by screening had fewer hospitalizations and ED visits than those diagnosed by usual care.

  • 1
    News

    SGLT2 inhibitors prevent HF hospitalization regardless of baseline LVEF

    May 9, 2019

    NEW ORLEANS – “At least in my mind, we have more than enough evidence at this point to say that SGLT2 inhibitors are effective in preventing heart failure,” Dr. Mikhail Kosiborod said.

  • 1
    News

    Quick Byte: Hope for HF patients

    May 8, 2019

    Device shows promise for heart failure patients.

  • 1
    News

    The search for a life-changing innovation

    May 7, 2019

    A new book documents the decades-long pursuit of an artificial heart.

  • News

    Single-center study outlines stroke risk, DOAC type in nonvalvular AFib patients

    May 6, 2019

    PHILADELPHIA –Rivaroxaban was more often than other DOACs associated with events in nonvalvular atrial fibrillation patients, based on a small study from a tertiary care center in Australia.

  • 1
    News

    Long-term antibiotic use may heighten stroke, CHD risk

    April 28, 2019

    Among middle-aged and older women, 2 or more months’ exposure to antibiotics is associated with an increased likelihood of cardiovascular disease.

  • 1
    News

    Epinephrine linked with more refractory cardiogenic shock after acute MI

    April 18, 2019

    Is there a difference in safety and efficacy when using epinephrine versus norepinephrine for cardiogenic shock after successful reperfusion in acute myocardial infarction (AMI)?

Previous1 … 47 48 49 50 51 … 80Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences